Microbiome Labs launches EpicDefense on Amazon

By: Newsfile
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

A science-first challenge to traditional immune support, now available directly for consumers

Franklinton, North Carolina--(Newsfile Corp. - May 18, 2026) - Microbiome Labs™, a leader in microbiome-based solutions, announces the official launch of EpicDefense™ on Amazon, expanding consumer access to its latest microbiome-focused immune-support formula.

EpicDefense is formulated to support the body's natural defenses and promote respiratory comfort through a direct, science-first approach*. With this launch, Microbiome Labs is delivering a professional-grade immunobiotic formula that shifts the focus from reactive supplementation to proactive, gut-powered resilience.

The formula combines clinically studied strains selected to support respiratory health and immune balance, including:

  • LGG (Lacticaseibacillus rhamnosus GG): Clinically shown to support upper respiratory health and maintain immune balance.
  • BB-12 (Bifidobacterium animalis subsp. lactis): Documented to support natural antibody response to immune challenges.
  • EpiCor®: A whole-food yeast fermentate that supports healthy nasal airflow and respiratory comfort.
  • Zinc Bisglycinate (Albion® Minerals): A chelated form of zinc optimized for absorption to enhance Natural Killer cell functionality.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/11973/297372_microbiome1_550.jpg

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11973/297372_microbiome1.jpg

"For too long, immune support has focused on short-term reactions rather than building resilient systems," says Alicia Galvin, MEd, RD, LD, IFNCP, head of scientific affairs at Microbiome Labs. "EpicDefense reflects a shift toward proactive, gut-powered defense grounded in clinical science and made accessible without compromising rigor. This launch represents our commitment to translating validated microbiome research into real-world solutions."

EpicDefense is non-GMO, soy-free and dairy-free, meeting the rigorous standards healthcare practitioners and microbiome experts expect. To learn more about the company's mission to pioneer health, visit microbiomelabs.com.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

###

About Microbiome Labs
Microbiome Labs, part of Novonesis Human Health Biosolutions, provides innovative, research-based solutions that support the body's microbial ecosystem. With a focus on clinical application and practitioner partnerships, Microbiome Labs delivers evidence-informed products designed to support overall wellness. Learn more at microbiomelabs.com.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297372

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  264.86
+0.72 (0.27%)
AAPL  297.84
-2.39 (-0.80%)
AMD  420.99
-3.11 (-0.73%)
BAC  50.69
+0.92 (1.85%)
GOOG  393.11
-0.21 (-0.05%)
META  611.39
-2.84 (-0.46%)
MSFT  423.54
+1.62 (0.38%)
NVDA  222.32
-3.00 (-1.33%)
ORCL  186.61
-6.34 (-3.29%)
TSLA  409.99
-12.25 (-2.90%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.